Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019Daniela K van Santen, Margaret Hellard, Colette Smit et al.|EClinicalMedicine|2022Cited by 38
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studiesRachel Sacks‐Davis, Coralie Khan, Daniela K van Santen et al.|The Lancet HIV|2024Cited by 24
All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019Maria-Bernarda Requena, Karine Lacombe, Camélia Protopopescu et al.|International Journal of Drug Policy|2024Cited by 5